These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 27805424)

  • 1. Accurate Determination of Soluble Axl by Enzyme-Linked Immunosorbent Assay.
    Dengler M; Huber H; Müller CJ; Zellmer A; Rauch P; Mikulits W
    Assay Drug Dev Technol; 2016 Nov; 14(9):543-550. PubMed ID: 27805424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multicenter analysis of soluble Axl reveals diagnostic value for very early stage hepatocellular carcinoma.
    Reichl P; Fang M; Starlinger P; Staufer K; Nenutil R; Muller P; Greplova K; Valik D; Dooley S; Brostjan C; Gruenberger T; Shen J; Man K; Trauner M; Yu J; Gao CF; Mikulits W
    Int J Cancer; 2015 Jul; 137(2):385-394. PubMed ID: 25529751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble Axl Is a Novel Diagnostic Biomarker of Hepatocellular Carcinoma in Chinese Patients with Chronic Hepatitis B Virus Infection.
    Song X; Wu A; Ding Z; Liang S; Zhang C
    Cancer Res Treat; 2020 Jul; 52(3):789-797. PubMed ID: 32138467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gas6 is complexed to the soluble tyrosine kinase receptor Axl in human blood.
    Ekman C; Stenhoff J; Dahlbäck B
    J Thromb Haemost; 2010 Apr; 8(4):838-44. PubMed ID: 20088931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble Axl is an accurate biomarker of cirrhosis and hepatocellular carcinoma development: results from a large scale multicenter analysis.
    Dengler M; Staufer K; Huber H; Stauber R; Bantel H; Weiss KH; Starlinger P; Pock H; Klöters-Plachky P; Gotthardt DN; Rauch P; Lackner C; Stift J; Brostjan C; Gruenberger T; Kumada T; Toyoda H; Tada T; Weiss TS; Trauner M; Mikulits W
    Oncotarget; 2017 Jul; 8(28):46234-46248. PubMed ID: 28526812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating soluble Axl as a biomarker for glioblastoma: A pilot study.
    Raymond D; Fukui M; Zwernik S; Kassam A; Rovin R; Akhtar P
    PLoS One; 2024; 19(7):e0301739. PubMed ID: 38968207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum levels of Growth Arrest-Specific 6 protein and soluble AXL in patients with ST-segment elevation myocardial infarction.
    Caldentey G; García De Frutos P; Cristóbal H; Garabito M; Berruezo A; Bosch X; San Antonio R; Flores-Umanzor E; Perea RJ; De Caralt TM; Rodríguez J; Ortiz-Pérez JT
    Eur Heart J Acute Cardiovasc Care; 2019 Dec; 8(8):708-716. PubMed ID: 29119801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The non-invasive serum biomarker soluble Axl accurately detects advanced liver fibrosis and cirrhosis.
    Staufer K; Dengler M; Huber H; Marculescu R; Stauber R; Lackner C; Dienes HP; Kivaranovic D; Schachner C; Zeitlinger M; Wulkersdorfer B; Rauch P; Prager G; Trauner M; Mikulits W
    Cell Death Dis; 2017 Oct; 8(10):e3135. PubMed ID: 29072690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated serum levels of soluble Axl in acute coronary syndrome.
    Liu YW; Yang QF; Zuo PY; Xiao CL; Chen XL; Liu CY
    Am J Med Sci; 2015 Feb; 349(2):124-9. PubMed ID: 25474223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble AXL as a marker of disease progression and survival in melanoma.
    Flem-Karlsen K; Nyakas M; Farstad IN; McFadden E; Wernhoff P; Jacobsen KD; Flørenes VA; Mælandsmo GM
    PLoS One; 2020; 15(1):e0227187. PubMed ID: 31917795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma concentrations of Gas6 (growth arrest specific protein 6) and its soluble tyrosine kinase receptor sAxl in sepsis and systemic inflammatory response syndromes.
    Ekman C; Linder A; Akesson P; Dahlbäck B
    Crit Care; 2010; 14(4):R158. PubMed ID: 20731857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma concentrations of sAxl are associated with severe preeclampsia.
    Liu X; Gong Y; Jia J; Bai Y; Gui S; Wang T; Zhou R
    Clin Biochem; 2014 Feb; 47(3):173-6. PubMed ID: 24239956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum GAS6, sAXL, IL-10, NO, and BCL-2 levels are decreased in patients with Behçet's disease.
    Baskol G; Yetkin MÖ; Sevim DG; Guclu K; Arda H; Saracoglu H; Gahramanov K; Evereklioglu C
    Indian J Ophthalmol; 2024 May; 72(Suppl 3):S468-S472. PubMed ID: 38648454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating levels of soluble MER in lupus reflect M2c activation of monocytes/macrophages, autoantibody specificities and disease activity.
    Zizzo G; Guerrieri J; Dittman LM; Merrill JT; Cohen PL
    Arthritis Res Ther; 2013; 15(6):R212. PubMed ID: 24325951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma levels of soluble Axl correlate with severity of community-acquired pneumonia.
    Ko CP; Yu YL; Hsiao PC; Yang SF; Yeh CB
    Mol Med Rep; 2014 Apr; 9(4):1400-4. PubMed ID: 24503651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AXL receptor tyrosine kinase is increased in patients with heart failure.
    Batlle M; Recarte-Pelz P; Roig E; Castel MA; Cardona M; Farrero M; Ortiz JT; Campos B; Pulgarín MJ; Ramírez J; Pérez-Villa F; García de Frutos P
    Int J Cardiol; 2014 May; 173(3):402-9. PubMed ID: 24681018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble AXL: a possible circulating biomarker for neurofibromatosis type 1 related tumor burden.
    Johansson G; Peng PC; Huang PY; Chien HF; Hua KT; Kuo ML; Chen CT; Lee MJ
    PLoS One; 2014; 9(12):e115916. PubMed ID: 25551830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma concentrations of Gas6 and sAxl correlate with disease activity in systemic lupus erythematosus.
    Ekman C; Jönsen A; Sturfelt G; Bengtsson AA; Dahlbäck B
    Rheumatology (Oxford); 2011 Jun; 50(6):1064-9. PubMed ID: 21278074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble Axl is generated by ADAM10-dependent cleavage and associates with Gas6 in mouse serum.
    Budagian V; Bulanova E; Orinska Z; Duitman E; Brandt K; Ludwig A; Hartmann D; Lemke G; Saftig P; Bulfone-Paus S
    Mol Cell Biol; 2005 Nov; 25(21):9324-39. PubMed ID: 16227584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased concentrations of plasma growth arrest-specific 6 and its soluble tyrosine kinase receptor sAxl in Taiwanese women with pelvic inflammatory disease.
    Chen SC; Ko JL; Yang SF; Tsai MY; Tsai HT; Tang CH; Wang PH
    Clin Chim Acta; 2013 Nov; 426():85-90. PubMed ID: 24045047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.